🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07037849
Recruiting Not applicable

The Effects of the Control Strategies of Wearable Lower Limb Rehabilitation Robots

NCT07037849 · tracked via the Priya Life Science China tracker
Sponsor
Eighth Affiliated Hospital, Sun Yat-sen University
Phase
Not applicable
Started
2024-10-23
Last updated
2025-06-26

Condition(s) studied

StrokeGait TrainingGait Disorders

Investigational drug(s) / intervention(s)

Robot-assisted overground gait training

Robot-assisted overground gait training: Post-stroke patients were required to complete a session of robot-assisted training, which involved nine repetitions of 5-meter overground walking (three trials for each of the three controllers).

Study summary

Post-stroke patients were required to complete a session of robot-assisted training, which involved nine repetitions of 5-meter overground walking (three trials for each of the three controllers) in a rectangular hospital corridor.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: Stroke patients aged between 18 and 75 years. Patients who are medically stable and able to stand and walk independently for at least 10 meters during rehabilitation. Stroke event occurred at least 3 months ago Patients with impaired lower limb motor function but with some degree of muscle activity in the lower extremities. Patients without severe cognitive impairment and capable of understanding and following the treatment protocol. Patients without severe balance or coordination disorders, able to maintain balance and perform gait training with assistive devices. Patients without lower limb fractures or other serious skeletal issues affecting the lower limbs. Patients without severe cardiovascular or other serious illnesses and able to tolerate the intensity and duration of rehabilitation therapy. Patients willing to participate in the study and able to provide written informed consent. Exclusion Criteria: Severe cognitive impairment that prevents the patient from understanding or complying with the treatment protocol. Severe balance or coordination disorders that prevent the patient from maintaining balance and participating in gait training, even with assistive devices. Other serious motor disorders, such as abnormal muscle tone or ataxia, which may interfere with the effectiveness of rehabilitation therapy. Active cardiovascular disease or other serious systemic illnesses that may affect the patient's safety or treatment outcomes. Lower limb fractures or other serious skeletal issues that may impact the suitability and safety of robot-assisted rehabilitation therapy. Patients currently receiving other rehabilitation or experimental treatments. Patients with skin ulcers, infections, or other severe skin conditions that may interfere with the use and application of robotic devices. Unexplained discomfort or pain symptoms that may limit the patient's ability to participate in rehabilitation therapy. Failure to meet other specific inclusion criteria outlined in the study protocol.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Eight affiliated hospital, Sun Yat-Sen University Shenzhen Guangzhou Recruiting

More Eighth Affiliated Hospital, Sun Yat-sen University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07037849 on ClinicalTrials.gov ↗ ← All trials in China